Search research articles
Contact Us
Filters
Showing results (231-240 of 564) with videos related to
Page
of 57
Sort By:
The Journal of Infectious Diseases
|
January 1, 1990
Severe cellulitis caused by group A streptococcus: Rx reading the Journal
M Fried, B Rudensky, J Golan, et al.
BJU International
|
April 1, 2010
Role of targeted therapy in the treatment of advanced prostate cancer
Karim Fizazi, Cora N Sternberg, John M Fitzpatrick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Irinotecan chemotherapy associated with transient dysarthria and aphasia
S De Marco, E Squilloni, L Vigna, et al.
Hematology/Oncology Clinics of North America
|
April 4, 2015
Future directions and targeted therapies in bladder cancer
Guru Sonpavde, Benjamin S Jones, Joaquim Bellmunt, et al.
Cancer
|
December 26, 2001
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy
C N Sternberg, F CalabrĂ², G Pizzocaro, et al.
Drugs
|
May 21, 2010
Castration-resistant prostate cancer: current and emerging treatment strategies
Giuseppe Di Lorenzo, Carlo Buonerba, Riccardo Autorino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2022
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis
Chiara Ciccarese, Roberto Iacovelli, Cora N Sternberg, et al.
Clinical Nuclear Medicine
|
April 8, 2026
Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone Flare
Valentina Marulanda-Corzo, Preeti Kakkar, Arman Sharbatdaran, et al.
Oncology
|
September 18, 2014
An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinoma
Cora N Sternberg, Ian D Davis, Keith C Deen, et al.
American Journal of Clinical Oncology
|
August 1, 1983
Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas
C N Sternberg, G B Magill, P P Sordillo, et al.
Page
of 57
Search research articles
Search
Showing results (231-240 of 564) with videos related to
Sort By:
Page
of 57
The Journal of Infectious Diseases
|
January 1, 1990
Severe cellulitis caused by group A streptococcus: Rx reading the Journal
M Fried, B Rudensky, J Golan, et al.
BJU International
|
April 1, 2010
Role of targeted therapy in the treatment of advanced prostate cancer
Karim Fizazi, Cora N Sternberg, John M Fitzpatrick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Irinotecan chemotherapy associated with transient dysarthria and aphasia
S De Marco, E Squilloni, L Vigna, et al.
Hematology/Oncology Clinics of North America
|
April 4, 2015
Future directions and targeted therapies in bladder cancer
Guru Sonpavde, Benjamin S Jones, Joaquim Bellmunt, et al.
Cancer
|
December 26, 2001
Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy
C N Sternberg, F CalabrĂ², G Pizzocaro, et al.
Drugs
|
May 21, 2010
Castration-resistant prostate cancer: current and emerging treatment strategies
Giuseppe Di Lorenzo, Carlo Buonerba, Riccardo Autorino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 14, 2022
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis
Chiara Ciccarese, Roberto Iacovelli, Cora N Sternberg, et al.
Clinical Nuclear Medicine
|
April 8, 2026
Stereotactic Body Radiation Therapy (SBRT)-Induced 68Ga-PSMA PET Bone Flare
Valentina Marulanda-Corzo, Preeti Kakkar, Arman Sharbatdaran, et al.
Oncology
|
September 18, 2014
An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinoma
Cora N Sternberg, Ian D Davis, Keith C Deen, et al.
American Journal of Clinical Oncology
|
August 1, 1983
Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas
C N Sternberg, G B Magill, P P Sordillo, et al.
Page
of 57